JP2023030113A5 - - Google Patents

Download PDF

Info

Publication number
JP2023030113A5
JP2023030113A5 JP2022205904A JP2022205904A JP2023030113A5 JP 2023030113 A5 JP2023030113 A5 JP 2023030113A5 JP 2022205904 A JP2022205904 A JP 2022205904A JP 2022205904 A JP2022205904 A JP 2022205904A JP 2023030113 A5 JP2023030113 A5 JP 2023030113A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
pharmaceutical combination
compound
subject
phenanthro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022205904A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023030113A (ja
JP7574268B2 (ja
Filing date
Publication date
Priority claimed from JP2020504267A external-priority patent/JP7263313B2/ja
Application filed filed Critical
Publication of JP2023030113A publication Critical patent/JP2023030113A/ja
Publication of JP2023030113A5 publication Critical patent/JP2023030113A5/ja
Application granted granted Critical
Publication of JP7574268B2 publication Critical patent/JP7574268B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022205904A 2017-04-10 2022-12-22 併用される抗真菌剤 Active JP7574268B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762483647P 2017-04-10 2017-04-10
US62/483,647 2017-04-10
JP2020504267A JP7263313B2 (ja) 2017-04-10 2018-04-04 併用される抗真菌剤
PCT/US2018/026088 WO2018191077A1 (en) 2017-04-10 2018-04-04 Antifungal agents used in combination

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020504267A Division JP7263313B2 (ja) 2017-04-10 2018-04-04 併用される抗真菌剤

Publications (3)

Publication Number Publication Date
JP2023030113A JP2023030113A (ja) 2023-03-07
JP2023030113A5 true JP2023030113A5 (cg-RX-API-DMAC7.html) 2023-11-17
JP7574268B2 JP7574268B2 (ja) 2024-10-28

Family

ID=62063223

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020504267A Active JP7263313B2 (ja) 2017-04-10 2018-04-04 併用される抗真菌剤
JP2022205904A Active JP7574268B2 (ja) 2017-04-10 2022-12-22 併用される抗真菌剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020504267A Active JP7263313B2 (ja) 2017-04-10 2018-04-04 併用される抗真菌剤

Country Status (13)

Country Link
US (2) US11110102B2 (cg-RX-API-DMAC7.html)
EP (1) EP3609539A1 (cg-RX-API-DMAC7.html)
JP (2) JP7263313B2 (cg-RX-API-DMAC7.html)
KR (1) KR102683355B1 (cg-RX-API-DMAC7.html)
CN (1) CN110769854B (cg-RX-API-DMAC7.html)
AR (1) AR113221A1 (cg-RX-API-DMAC7.html)
AU (1) AU2018253031B2 (cg-RX-API-DMAC7.html)
CA (1) CA3059225A1 (cg-RX-API-DMAC7.html)
EA (1) EA201992413A1 (cg-RX-API-DMAC7.html)
MA (1) MA49889A (cg-RX-API-DMAC7.html)
MX (1) MX2019012116A (cg-RX-API-DMAC7.html)
TW (1) TWI806861B (cg-RX-API-DMAC7.html)
WO (1) WO2018191077A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3661503T3 (pl) * 2017-08-04 2023-01-09 Scynexis, Inc. Środki przeciwgrzybicze o zwiększonej aktywności przy kwasowym odczynie ph
AU2020228036B2 (en) * 2019-02-27 2025-08-07 Scynexis, Inc. Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia
AU2020276595B2 (en) * 2019-05-16 2025-12-04 Scynexis, Inc. Antifungal Agents for Candida Auris Decolonization

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
ES2402659T3 (es) 2006-04-03 2013-05-07 Merck Sharp & Dohme Corp. Derivados de enfumafungina como agentes antifúngicos
WO2010019204A1 (en) * 2008-08-12 2010-02-18 Merck Sharp & Dohme Corp. Antifungal agents
BRPI0912074B1 (pt) * 2008-08-12 2021-08-03 Merck Sharp & Dohme Corp Composto e composição farmacêutica
PL3221308T3 (pl) * 2014-11-21 2019-03-29 F2G Limited Środki przeciwgrzybicze
PT3247711T (pt) 2015-01-19 2022-05-16 Scynexis Inc Novos sais e polimorfos de scy-078

Similar Documents

Publication Publication Date Title
JP2021063088A5 (cg-RX-API-DMAC7.html)
JP2023002662A5 (cg-RX-API-DMAC7.html)
JP2022191257A5 (cg-RX-API-DMAC7.html)
JP2022545835A5 (cg-RX-API-DMAC7.html)
JP2021534160A5 (cg-RX-API-DMAC7.html)
JP2006523216A5 (cg-RX-API-DMAC7.html)
JP2017536371A5 (cg-RX-API-DMAC7.html)
JP2023116697A5 (cg-RX-API-DMAC7.html)
BRPI0712843A2 (pt) antagonista de ccr5 e seus usos
JP2022516662A5 (cg-RX-API-DMAC7.html)
JP2019529574A5 (cg-RX-API-DMAC7.html)
ES2389539T3 (es) Métodos y composiciones para el tratamiento del asma
JP2020513037A5 (cg-RX-API-DMAC7.html)
JP2022533981A5 (cg-RX-API-DMAC7.html)
US20200147081A1 (en) Use of Kinase Inhibitors to Manage Tuberculosis and Other Infectious Diseases
JP2023531930A5 (cg-RX-API-DMAC7.html)
JP2025118775A5 (cg-RX-API-DMAC7.html)
JP2023553253A5 (cg-RX-API-DMAC7.html)
JP2020529999A5 (cg-RX-API-DMAC7.html)
JP2022550734A5 (cg-RX-API-DMAC7.html)
JP2023530936A5 (cg-RX-API-DMAC7.html)
JP2025517509A5 (cg-RX-API-DMAC7.html)
JP2022543679A5 (cg-RX-API-DMAC7.html)
CN107224431A (zh) 非布司他改进的释放剂型及其制备方法
CA2464309A1 (en) Combinations comprising a selective cyclooxygenase-2 inhibitor